BICO Group AB (FRA:49Z) ROCE % : -3.70% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is BICO Group AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BICO Group AB's annualized ROCE % for the quarter that ended in Sep. 2024 was -3.70%.

BICO Group AB ROCE % Historical Data

The historical data trend for BICO Group AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB ROCE % Chart

BICO Group AB Annual Data

Trend

Aug16

Aug17

Aug18

Aug19

Aug20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

0.04

-6.19

-2.91

0.67

-19.24

BICO Group AB Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-0.49	-74.92	0.78	-3.28	-3.70

BICO Group AB ROCE % Calculation

BICO Group AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-141.623	/	( ( (927.518 - 85.458)	+	(706.041 - 75.719) )	/ 2 )
	=	-141.623	/	( (842.06	+	630.322)	/ 2 )
	=	-141.623	/	736.191
	=	-19.24 %

BICO Group AB's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-16.172	/	( ( (504.523 - 53.364)	+	(481.919 - 59.227) )	/ 2 )
	=	-16.172	/	( ( 451.159	+	422.692 )	/ 2 )
	=	-16.172	/	436.9255
	=	-3.70 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

BICO Group AB (FRA:49Z) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BICO Group AB ROCE % Related Terms

Thank you for viewing the detailed overview of BICO Group AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BICO Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

BCCOY:USA CLLKF:USA BICO:Sweden

Address

Langfilsgatan 9, Gothenburg, SWE, 41277

Website

https://www.bico.com

BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB Headlines

No Headlines